Diabetic Foot Ulcer Management: Vascular, Neurologic, and Preventive Guidelines
Vascular Assessment and Revascularization
- All patients with diabetic foot ulcers should receive immediate comprehensive vascular assessment, infection evaluation, and pressure off‑loading; urgent vascular imaging and revascularization are indicated when toe pressure is < 30 mmHg or transcutaneous oxygen pressure (TcPO₂) is < 25 mmHg. 1
- Ankle systolic pressure and ankle‑brachial index (ABI) must be measured with Doppler arterial waveforms in every patient with a diabetic foot ulcer. 1
- Bedside non‑invasive tests that effectively exclude peripheral artery disease (PAD) are: ABI 0.9–1.3, toe‑brachial index ≥ 0.75, or triphasic pedal Doppler waveforms. 1
- Urgent vascular imaging and revascularization are also warranted when ankle pressure is < 50 mmHg or ABI < 0.5, and when an ulcer does not improve within 6 weeks despite optimal care. 1
- Full lower‑extremity arterial mapping—including below‑the‑knee and pedal arteries—should be performed to guide revascularization planning. 1
- The revascularization goal is to restore direct flow to at least one foot artery, achieving skin perfusion pressure ≥ 40 mmHg, toe pressure ≥ 30 mmHg, or TcPO₂ ≥ 25 mmHg. 1
- Both endovascular techniques and surgical bypass must be available; the choice should be made by a multidisciplinary team based on PAD morphology, autogenous vein availability, patient comorbidities, and local expertise. 1
- Patients with PAD and a foot infection are at especially high risk for major limb amputation and require emergency treatment. 1
- Poor wound healing should not be attributed primarily to diabetic microangiopathy (“small‑vessel disease”). 1
Neuropathy Assessment
- Pressure perception should be tested with a 10‑g Semmes‑Weinstein monofilament. 2
- Vibration perception should be assessed using a 128‑Hz tuning fork. 2
- Pin‑prick discrimination on the dorsal foot and tactile sensation with cotton wool should be evaluated. 2
- Achilles tendon reflexes should be examined. 2
Pressure Off‑Loading, Footwear, and Daily Care
- Patients must be instructed not to walk barefoot, in socks only, or in thin‑soled standard slippers. 3
- For recurrent plantar ulcers, therapeutic footwear that reduces plantar pressure by approximately 30 % compared with standard therapeutic shoes should be prescribed. 3
- Daily foot and shoe‑inside inspection, washing, and careful drying between the toes are recommended. 3
- Emollients should be used for dry skin; chemical agents or plasters for callus removal should be avoided. 3
- Integrated foot care—including professional foot treatment, appropriate footwear, and patient education—should be repeated every 1–3 months to prevent ulcer recurrence. 3
- Pre‑ulcerative signs should be managed by removing callus, protecting blisters, treating ingrown or thickened toenails, and prescribing antifungal therapy for fungal infections. 3
- Toenails should be cut straight across. 3
Monitoring Frequency (IWGDF Risk Classification)
| Risk Category | Clinical Features | Recommended Monitoring Interval |
|---|---|---|
| Category 0 – No peripheral neuropathy | – | Annual examination |
| Category 1 – Peripheral neuropathy only | – | Every 6 months |
| Category 2 – Neuropathy + PAD and/or foot deformity | – | Every 3–6 months |
| Category 3 – Neuropathy + history of ulcer or amputation | – | Every 1–3 months |
Monitoring intervals are based on the International Working Group on the Diabetic Foot (IWGDF) risk classification.* 2
Diabetic Foot Management Guideline
Standard of Care Approaches
- Comprehensive foot evaluation should be performed at least annually to identify risk factors for ulcers and amputations, as recommended by the American Diabetes Association 4
- Patients with diabetes should have their feet inspected at every visit, with more frequent detailed assessments for those with histories of ulcers, amputations, or foot deformities, according to the American Diabetes Association 4
- Appropriate wound care with debridement, infection management, and off-loading pressure from wounds are essential components of diabetic foot management, as stated by the Infectious Diseases Society of America 5
- Sharp debridement with scalpel, scissors, or tissue nippers is generally preferable to hydrotherapy or topical debriding agents for infected wounds, as recommended by the Infectious Diseases Society of America 5
Antimicrobial Therapy
- Most diabetic foot infections are polymicrobial, with aerobic gram-positive cocci being the most common causative organisms, according to the American Diabetes Association 6, 7
- Wounds without evidence of soft tissue or bone infection do not require antibiotic therapy, as stated by the American Diabetes Association 6
- Empiric antibiotic therapy can be narrowly targeted at gram-positive cocci in many patients with acute infections, according to the American Diabetes Association 7
- Patients at risk for infection with antibiotic-resistant organisms or with chronic, previously treated, or severe infections require broader-spectrum regimens and should be referred to specialized care centers, as recommended by the American Diabetes Association 7
Advanced Therapies for Chronic Diabetic Foot Ulcers
- For chronic diabetic foot ulcers that have failed to heal with optimal standard care alone, adjunctive treatment with randomized controlled trial-proven advanced agents should be considered, as stated by the American Diabetes Association 4
- Considerations might include negative-pressure wound therapy, placental membranes, bioengineered skin substitutes, acellular matrices, autologous fibrin and leukocyte platelet patches, and topical oxygen therapy, according to the American Diabetes Association 4
- Sucrose-octasulfate impregnated dressing may be considered as an adjunctive treatment for non-infected, neuro-ischemic diabetic foot ulcers that have had insufficient change with best standard care, as recommended by the European Association for the Study of Diabetes 8
Limitations and Concerns
- Current clinical guidelines for diabetic foot management (including the International Working Group on the Diabetic Foot and American Diabetes Association) do not include sulodexide among recommended treatments, due to lack of sufficient evidence, as stated by the American Diabetes Association 4, 5, 9, 10
- The guidelines specifically evaluate numerous interventions for diabetic foot ulcers but do not mention sulodexide as an established or emerging therapy, according to the European Association for the Study of Diabetes 8, 9, 10